Co-expression with RAS mutations to drive tumourigenesis [82]Co-expression with tumour portein (TP) 53/Telomerase reverse transcriptase (TERT) mutationsin biologically aggressive tumours [82]. This evidence concerns the gene TERT and neoplasm.